Skip to main content
Aurora Cannabis Inc. logo

Aurora Cannabis Inc. — Investor Relations & Filings

Ticker · ACB ISIN · CA05156X8504 TSX Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2025-06-18 Regulatory Filings
Country CA Canada
Listing TSX ACB

About Aurora Cannabis Inc.

https://www.auroramj.com/

Aurora Cannabis Inc. is a global leader in the production and distribution of cannabis and cannabis-derivative products. The company cultivates and sells a portfolio of products for both medicinal and recreational markets. Recognized as Canada's largest medical cannabis company and a trusted provider, Aurora focuses on innovative, science-based medical cannabis offerings, including dried flower and various derivative formats such as oils and edibles. The company maintains operations across 12 countries, emphasizing high-quality cultivation and rigorous product development to serve patients and consumers worldwide.

Recent filings

Filing Released Lang Actions
52-109F1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 85% confidence The document is a Form 52-109F1 “Certification of Annual Filings” completed by the issuer’s CEO under Canadian National Instrument 52-109. It is a regulatory submission/certification rather than the full annual report (10-K/Annual Report) itself, an audit report from external auditors, or an announcement of a report’s publication. It does not fit specialized categories like audit reports, earnings releases, management changes, or capital actions. Therefore it is best classified as a general regulatory filing.
2025-06-18 English
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 62% confidence The document is a standalone certification (Form 52-109F1) by the issuer’s CFO attesting to the review and design of disclosure controls and internal controls over financial reporting for the fiscal year. It is not the full annual report or MD&A, not an audit opinion from external auditors, nor an earnings release or other predefined category. It is a regulatory compliance certificate filed under Canadian NI 52-109, so it falls under the general Regulatory Filings category (RNS).
2025-06-18 English
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled “Management’s Discussion & Analysis” (MD&A) for the year ended March 31, 2025. It contains a detailed narrative of financial condition, results of operations, business overview, strategy, liquidity, accounting policies, risk factors, and other management commentary. This matches the description of Management Reports (Code: MDA) – a detailed explanation of financial results, business trends, and outlook. It is not a brief earnings release, an announcement of report publication, or an annual report itself, but specifically the standalone MD&A section.
2025-06-18 English
Annual information form - English.pdf
Regulatory Filings Classification · 85% confidence The document is titled “Annual Information Form” for the year ended March 31, 2025 and contains forward-looking statements, corporate structure, business description, risk factors, capital structure, directors and officers, legal proceedings, audit committee charter, etc. It is not a US 10-K annual report with full financial statements, nor an earnings release or proxy statement. It is a regulatory continuous disclosure filing specific to Canadian issuers (NI 51-102 AIF), which does not fit any of the other narrow categories. Therefore it defaults to the general Regulatory Filings category (RNS).
2025-06-18 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 85% confidence The document is a completed OSC Form 13-502F1 submitted to the Ontario Securities Commission to calculate and certify participation fees under OSC Rule 13-502 Fees. It is a statutory regulatory form rather than an annual or interim financial report, earnings release, or investor presentation. It does not announce publication of a separate report but is itself a regulatory submission, thus fitting the fallback category “Regulatory Filings” (RNS).
2025-06-18 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 85% confidence The document is a completed Form 13-501F1 filed with the Alberta Securities Commission, certifying participation fees based on market values for specified trading periods. It is neither an annual or interim financial report, nor an earnings release, proxy statement, governance or ESG report, nor any other specialized category. It is a regulatory submission/form, best classified under the general Regulatory Filings category (RNS).
2025-06-18 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.